Abstract
Checkpoints regulate the normal progression of the cell cycle. Disturbance in the normal function of these checkpoints can induce genomic instability, which is associated with cancer initiation. One such form of instability, aneuploidy, can result from alterations of cell cycle checkpoints, and can induce large imbalances in gene copy number. These imbalances could, in turn, alter the expression of gene products involved in cancer development.
Keywords: Aneuploidy, CELL CYCLE REGULATION, Cell Cycle Kinases, CENTRIOLE
Current Genomics
Title: Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review
Volume: 2 Issue: 2
Author(s): William G. Kearns and Johnson M. Liu
Affiliation:
Keywords: Aneuploidy, CELL CYCLE REGULATION, Cell Cycle Kinases, CENTRIOLE
Abstract: Checkpoints regulate the normal progression of the cell cycle. Disturbance in the normal function of these checkpoints can induce genomic instability, which is associated with cancer initiation. One such form of instability, aneuploidy, can result from alterations of cell cycle checkpoints, and can induce large imbalances in gene copy number. These imbalances could, in turn, alter the expression of gene products involved in cancer development.
Export Options
About this article
Cite this article as:
Kearns G. William and Liu M. Johnson, Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013350931
DOI https://dx.doi.org/10.2174/1389202013350931 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Current Cancer Drug Targets Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases
Current Drug Targets HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies
Current Pharmaceutical Design Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets DNA Repair Proteins as Molecular Therapeutics for Oxidative and Alkylating Lung Injury
Current Gene Therapy Differential Expression of miR-20a and miR-145 in Colorectal Tumors as Potential Location-specific miRNAs
MicroRNA DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy
Current Cancer Drug Targets Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
Current Gene Therapy New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Anti-Cancer Agents in Medicinal Chemistry Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia
Current Molecular Medicine The MCM Complex: Its Role in DNA Replication and Implications for Cancer Therapy
Current Cancer Drug Targets Synthesis and Preliminary Cytotoxicity Studies of 1-[1-(4,5-Dihydrooxazol- 2-yl)-1H-indazol-3-yl]-3-phenylurea and 3-phenylthiourea Derivatives
Medicinal Chemistry Cell Cycle as a Target of Antineoplastic Drugs
Current Pharmaceutical Design Integrated Genomic and Pharmacological Approaches to Identify Synthetic Lethal Genes as Cancer Therapeutic Targets
Current Molecular Medicine Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets CYP24A1 as a Potential Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Current Neuropharmacology Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Current Drug Targets Stem Cell Function, Self-Renewal, Heterogeneity, and Regenerative Potential in Skeletal Muscle Stem Cells
Recent Patents on Regenerative Medicine Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets